TERN Valuation
Terns Pharmaceuticals Inc
$
3.020
- Overview
- Forecast
- Valuation
- Earnings
TERN Relative Valuation
TERN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TERN is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.77
P/B
Median3y
1.52
Median5y
1.40
-29.41
FCF Yield
Median3y
-21.42
Median5y
-23.02
Competitors Valuation Multiple
The average P/S ratio for TERN's competitors is 3.70, providing a benchmark for relative valuation. Terns Pharmaceuticals Inc Corp (TERN) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch
JMIA
Jumia Technologies AG
3.240
USD
-0.92%
AMPX
Amprius Technologies Inc
2.710
USD
+7.54%
CYRX
Cryoport Inc
6.040
USD
-2.89%
NYXH
Nyxoah SA
7.740
USD
-6.97%
HLLY
Holley Inc
1.970
USD
-2.48%
HBCP
Home Bancorp Inc
49.090
USD
-1.15%
LND
BrasilAgro Brazilian Agricultural Real Estate Co
3.850
USD
+1.32%
ZEUS
Olympic Steel Inc
30.090
USD
-1.63%
HOUS
Anywhere Real Estate Inc
3.340
USD
+3.73%
LGTY
Logility Supply Chain Solutions Inc
0
USD
+0.07%
FAQ
Is Terns Pharmaceuticals Inc (TERN) currently overvalued or undervalued?
Terns Pharmaceuticals Inc (TERN) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 12.39. The fair price of Terns Pharmaceuticals Inc (TERN) is between to according to relative valuation methord.
What is Terns Pharmaceuticals Inc (TERN) fair value?
How does TERN's valuation metrics compare to the industry average?
What is the current P/B ratio for Terns Pharmaceuticals Inc (TERN) as of May 24 2025?
What is the current FCF Yield for Terns Pharmaceuticals Inc (TERN) as of May 24 2025?
What is the current Forward P/E ratio for Terns Pharmaceuticals Inc (TERN) as of May 24 2025?